Compass Therapeutics, Inc.CMPXNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank43
Studio
Year-over-Year Change

Return on equity

Latest
-33.79%
↓ 49% vs avg
Percentile
P43
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
-22.68%
Historical baseline
PeriodValueYoY Change
2025-33.79%+14.3%
2024-39.43%-37.8%
2023-28.61%-32.5%
2022-21.60%+63.2%
2021-58.67%+20.6%
2020-73.85%-352.1%
201929.29%-35.1%
201845.16%-